Evidence against chronic antigen-specific T lymphocyte activation in myasthenia gravis

Journal of Neuroscience Research

Volumn 45, Issue 4, 1996, Pages 492-499

  Infante, A J ^a   Infante, P D ^a   Jackson, C E ^a   Barohn, R J ^c   Tami, J ^a   Iturriaga, E ^a   Talib, S ^d   Kraig, E ^b   Clarkin, K Z ^b   Krolick, K A ^b  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d UTHSCSA Pediatrics ^*  (United States)

Author keywords

acetylcholine receptor; hprt mutant selection; soluble IL 2 receptor; T cell activation

Indexed keywords

ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CLONAL ANERGY; GENE MUTATION; HELPER CELL; HUMAN; HUMAN CELL; MARKER GENE; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODY SPECIFICITY; CHRONIC DISEASE; CLONE CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; MYASTHENIA GRAVIS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CHOLINERGIC; RECEPTORS, INTERLEUKIN-2; RECOMBINANT PROTEINS; SOLUBILITY; T-LYMPHOCYTES; TORPEDO;

EID: 9544249347     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960815)45:4<492::AID-JNR20>3.0.CO;2-1     Document Type: Article

References (28)

1. Allegretta M, Nicklas JA, Sriram S, Albertini RJ (1990): T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247:718-721.
2. + T cell clone from a myasthenia gravis patient. J Neuroimmunol 46:57-65.
3. Barohn R and Jackson CE (1994). New classification system for myasthenia gravis. J Child Neurol 9:205-206.
4. Bellone M, Ostlie N, Lei SL, Conti-Tronconi BM (1991): Experimental myasthenia gravis in congenic mice: Sequence mapping and H-2 restriction of T helper epitopes on the α-subunits of Torpedo californica and murine acetylcholine receptors. Eur J Immunol 21:2303-2310.
5. Berrih-Aknin S, Cohen-Kaminsky S, Lepage V, Neumann D, Bach JF, Fuchs S (1991): T-cell antigenic sites involved in myasthenia gravis: Correlation with antibody liters and disease severity. J Autoimmunity 4:137-153.
6. Clark EA, Ledbetter JA (1994): How B and T cells talk to each other. Nature 367:425-428.
7. Confalonieri P, Antozzi C, Cornelio F, Simoncini O, Mantegazza R (1993): Immune activation in myasthenia gravis: Soluble interleukin-2 receptor, Interferon-γ and tumor necrosis factor-α levels in patients' serum. J Neuroimmunol 48:33-36.
8. Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, Ricci M, Romagnani S (1991): Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 helper or type 2 helper) profile of cytokine production. J Clin Invest 88:346-350.
9. Drachman DD (1994). Myasthenia gravis. N Engl J Med 330:1797-1810.
10. Gmelig-Meyling F, Dawisha S, Steinberg AD (1992): Assessment of in vivo frequency of mutated T cells in patients with systemic lupus erythematosus. J Exp Med 175:297-300.
11. Johnson BE, Sakaguchi AY, Gazder AF, Minna JD, Burch D, Marshall A, Naylor SL (1988): Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumors. J Clin Invest 82:502-507.
12. Kaul R, Shenoy M, Christadoss P (1994): The role of major histocompatibility complex genes in myasthenia gravis and experimental autoimmune myasthenia gravis pathogenesis. Adv Neuroimmunol 4:387-402.
13. Kraig E, Kannapell CC, Fischbach K, Zellmer V, Trial J (1990): Two ultraviolet tumor-specific suppressor cell clones: One expresses Ig RNA and the other expresses T cell receptor a and b RNA. J Immunol 145:2050-2056.
14. Lamont A (1994): Are we any closer to selective immunotherapy for autoimmune diseases? Immunol Today 15:45-47.
15. Lindstrom J, Shelton D, Fujii Y (1988): Myasthenia gravis. Adv Immunol 42:233-284.
16. Manfredi AA, Protti MP, Bellone M, Moiola L, Conti-Tronconi BM (1992): Molecular anatomy of an autoantigen: T and B cell epitopes on the nicotinic acetylcholine receptor in myasthenia gravis. J Lab Clin Med 120:13-21.
17. Matsuo H, Batocchi AP, Hawke S, Nicolle M, Jacobson L, Vincent A, Newsom-Davis J, Willcox N (1995): Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. J Immunol 155:3683-3692.
18. Melms A, Schalke BCG, Kirchner T, Muller-Hermelink HK, Albert E, Wekerle H (1988): Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J Clin Invest 81:902-908.
19. Melms A, Malcherek G, Gern U, Wietholter H, Muller CA, Schoepfer R, Lindstrom J (1992): T cells from normal and myasthenic individuals recognize the human acetylcholine receptor; Heterogeneity of antigenic sites on the α-subunit. Ann Neurol 31:311-318.
20. Melms A, Weissert R, Klinkert WEF, Schalke BCG, Szartos S, Wekerle H (1993): Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation. Neurology 43:583-588.
21. Nakano S, Engel AG (1993): Myasthenia gravis: Quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients. Neurology 43:1167-72.
22. Sun JB, Harcourt G, Wang ZY, Hawke S, Olsson T, Fredrikson S, Link H (1992): T cell responses to human recombinant acetylcholine receptor-α subunit in myasthenia gravis and controls. Eur J Immunol 22:1553-1559.
23. Talib S, Leiby KR, Wright K, Okarma TB (1991): Cloning and ex- pression in E coli of a synthetic gene encoding the extracellular domain of the human muscle acetylcholine receptor α-subunit. Gene 98:289-293.
24. Tami J, Jackson CE, Barohn RJ, McIntyre W, Krolick K (1995). Evaluation of soluble interleukin-2 receptors in the serum of myasthenia gravis patients. Neurology 45:A353.
25. Tournier-Lasserve E, Bach JF (1993): The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models. J Neuroimmunol 47:103-114.
26. Toyka KV, Drachman, DB, Pestronk A, Kao I (1975): Myasthenia gravis: Passive transfer from man to mouse. Science 190:397-399.
27. Steinman L and Mantegazza R (1990): Prospects for specific immunotherapy in myasthenia gravis. FASEB J 4:2726-2731.
28. b binding, self-nonself discrimination, and TCR antagonism. J Immunol 152:4526-4536.